Veno occlusive disease: Update on clinical management

Table 1 Risk factors for the development of VOD

1	Pre existing liver disease (hepatitis C, previous fibrosis, hypertransaminasemia)
2	Previous exposure to a myeloablative regimen
3	Past history of HSOS
4	Use of myeloablative regimen
5	High dose of total body irradiation
6	Use of cyclophosphamide containing regimes
7	Administration of cyclophosphamide after busulfan
8	Fixed dose of Busulfan
9	Use of oral rather than ev Busulfan
10	Late timing of SCT in patients with leukaemia
11	Carriers of haemocromathosis C282Y allele